Showing results (131-140 of 197) with videos related to
Sort By:
Pageof 20
Antimicrobial Agents and Chemotherapy|May 1, 1982
In vitro susceptibility of Clostridium difficile isolates to cefotaxime, moxalactam, and cefoperazoneR A Greenfield, T A Kurzynski, W A CraigJournal of Pharmaceutical Sciences|August 1, 1982
An in vitro model for the study of antibacterial dosage regimen designR D Toothaker, P G Welling, W A CraigThe Journal of Infectious Diseases|October 1, 1989
Use of serum ultrafiltrate in the serum dilution testJ E Leggett, S A Wolz, W A CraigJournal of Pharmaceutical Sciences|October 1, 1982
Effect of dose size on the pharmacokinetics of oral hydrocortisone suspensionR D Toothaker, W A Craig, P G WellingJAMA|February 12, 1988
Infectious complications in four long-term recipients of the Jarvik-7 artificial heartC M Kunin, J J Dobbins, J C Melo, et al.Reviews of Infectious Diseases|March 1, 1983
Pharmacokinetics of cefoperazone in patients with normal and impaired hepatic and renal functionR A Greenfield, A U Gerber, W A CraigAntimicrobial Agents and Chemotherapy|July 1, 1991
Correlation between in vitro and in vivo activity of antimicrobial agents against gram-negative bacilli in a murine infection modelB Fantin, J Leggett, S Ebert, et al.The Journal of Antimicrobial Chemotherapy|February 7, 2001
Evidence to support the rationale that bacterial eradication in respiratory tract infection is an important aim of antimicrobial therapyR Dagan, K P Klugman, W A Craig, et al.The Journal of Antimicrobial Chemotherapy|July 1, 1994
The postantibiotic effect of antifungal agents against common pathogenic yeastsJ D Turnidge, S Gudmundsson, B Vogelman, et al.Scandinavian Journal of Infectious Diseases. Supplementum|January 1, 1990
Comparative dose-effect relations at several dosing intervals for beta-lactam, aminoglycoside and quinolone antibiotics against gram-negative bacilli in murine thigh-infection and pneumonitis modelsJ E Leggett, S Ebert, B Fantin, et al.Pageof 20